Movie
Controller
Structure viewers
About EMN search
-Search query
-Search result
Showing 1 - 50 of 405 items for (author: ozorowski & g)
EMDB-42907: 
sRT-V2t NFL trimer in complex with 12CA5 Fab and RM20A3 Fab
Method: single particle / : Lee WH, Ozorowski G, Ward AB
EMDB-42908:
sRT-V1 NFL trimer in complex with 12CA5 Fab
Method: single particle / : Lee WH, Ozorowski G, Ward AB
EMDB-42909:
sRT-V3 NFL trimer in complex with 12CA5 Fab and RM20A3 Fab
Method: single particle / : Lee WH, Ozorowski G, Ward AB
EMDB-42910:
sRT-Bttm NFL trimer in complex with 12CA5 Fab
Method: single particle / : Lee WH, Ozorowski G, Ward AB
EMDB-42912:
sRT-C3V5 NFL trimer in complex with 12CA5 Fab and RM20A3 Fab
Method: single particle / : Lee WH, Ozorowski G, Ward AB
EMDB-42913:
sRT-V4 NFL trimer in complex with 12CA5 Fab and RM20A3 Fab
Method: single particle / : Lee WH, Ozorowski G, Ward AB
EMDB-41869:
BG505.664 SOSIP in complex with polyclonal antibodies from NHP 8131 (gp120 glycan hole, gp41 glycan hole/fusion peptide and trimer base epitopes)
Method: single particle / : Zhang S, Ward AB
EMDB-41870:
BG505.664 Env SOSIP in complex with polyclonal antibodies from NHP 8131 (gp120-gp120 interface epitope)
Method: single particle / : Zhang S, Ward AB
EMDB-41871:
BG505.664 Env SOSIP in complex with polyclonal antibodies from NHP 8147 (C3/V5, V1/V2/V3 apex, gp41 glycan hole/fusion peptide and trimer base epitopes)
Method: single particle / : Zhang S, Ward AB
EMDB-41872:
BG505.664 Env SOSIP in complex with polyclonal antibodies from NHP 8147 (gp120 glycan hole epitope)
Method: single particle / : Zhang S, Ward AB
EMDB-41972:
GT1.1 SOSIP in complex with wk39 polyclonal antibodies from NHP A12N030 (CD4bs, C3V5 and base epitopes)
Method: single particle / : van Schooten J, Ozorowski G, Ward AB
EMDB-41973:
GT1.1 SOSIP in complex with wk39 polyclonal antibodies from NHP A12N030 (gp41GH/FP and base epitopes)
Method: single particle / : van Schooten J, Ozorowski G, Ward AB
EMDB-41974:
GT1.1 SOSIP in complex with wk39 polyclonal antibodies from NHP DC8G (gp41GH/FP and gp120GH epitopes)
Method: single particle / : van Schooten J, Ozorowski G, Ward AB
EMDB-41975:
GT1.1 SOSIP in complex with wk39 polyclonal antibodies from NHP DC8G (gp120GH and base epitopes)
Method: single particle / : van Schooten J, Ozorowski G, Ward AB
EMDB-41976:
GT1.1 SOSIP in complex with wk39 polyclonal antibodies from NHP DC8G (V1V2V3 and gp120GH epitopes)
Method: single particle / : van Schooten J, Ozorowski G, Ward AB
EMDB-41977:
GT1.1 SOSIP-CC2 in complex with wk80 polyclonal antibodies from NHP 8229 (V1V2V3, C3V5, CD4bs, gp41GH/FP and base epitopes)
Method: single particle / : Sewell LM, Ozorowski G, Ward AB
EMDB-41978:
GT1.1 SOSIP-CC2 in complex with wk80 polyclonal antibodies from NHP 8239 (gp120GH, gp41GH/FP, CD4bs, and base epitopes)
Method: single particle / : Sewell LM, Ozorowski G, Ward AB
EMDB-40796:
BG505 GT1.1 SOSIP in complex with NHP Fabs 12C11 and RM20A3
Method: single particle / : Zhang S, Torres JL, Ozorowski G, Ward AB
PDB-8sw3:
BG505 GT1.1 SOSIP in complex with NHP Fabs 12C11 and RM20A3
Method: single particle / : Zhang S, Torres JL, Ozorowski G, Ward AB
EMDB-41498:
HIV-1 BG505 Env SOSIP in complex with bovine Fab Bess4 and non-human primate Fab RM20A3
Method: single particle / : Ozorowski G, Lee WH, Ward AB
PDB-8tq1:
HIV-1 BG505 Env SOSIP in complex with bovine Fab Bess4 and non-human primate Fab RM20A3
Method: single particle / : Ozorowski G, Lee WH, Ward AB
EMDB-42516:
HIV-1 JR-FL NFL.664 soluble trimer in complex with polyclonal Fab from rabbit U5902
Method: single particle / : Lee WH, Ozorowski G, Ward AB
EMDB-42517:
HIV-1 JR-FL NFL.664 soluble trimer in complex with polyclonal Fab from rabbit U5756
Method: single particle / : Lee WH, Ozorowski G, Ward AB
EMDB-42518:
HIV-1 1086c NFL.664 soluble trimer in complex with polyclonal Fab from rabbit U5403
Method: single particle / : Lee WH, Ozorowski G, Ward AB
EMDB-42519:
HIV-1 1086c NFL.664 soluble trimer in complex with polyclonal Fab from rabbit U5919
Method: single particle / : Lee WH, Ozorowski G, Ward AB
EMDB-40981:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody FP3
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB
EMDB-40982:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody N289
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB
PDB-8t2e:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody FP3
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB
PDB-8t2f:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody N289
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB
EMDB-40797:
BG505 GT1.1 SOSIP in complex with NHP Fabs 21N13, 21M20 and RM20A3
Method: single particle / : Ozorowski G, Torres JL, Zhang S, Ward AB
PDB-8sw4:
BG505 GT1.1 SOSIP in complex with NHP Fabs 21N13, 21M20 and RM20A3
Method: single particle / : Ozorowski G, Torres JL, Zhang S, Ward AB
EMDB-29330:
N332-GT5 SOSIP in complex with base polyclonal Fabs isolated at day 42 from protein immunized wild type mice
Method: single particle / : Torres JL, Jackson AM, Ozorowski G, Ward AB
EMDB-29333:
N332-GT5 SOSIP in complex with base polyclonal Fabs isolated at day 42 from protein immunized BG18HCgl knock-in mice
Method: single particle / : Torres JL, Jackson AM, Ozorowski G, Ward AB
EMDB-29334:
N332-GT5 SOSIP in complex with V1V3 polyclonal Fabs isolated at day 16 from mRNA immunized wild type mice
Method: single particle / : Torres JL, Jackson AM, Ozorowski G, Ward AB
EMDB-29335:
N332-GT5 SOSIP in complex with V1V3 polyclonal Fabs isolated at day 42 from mRNA immunized BG18HCgl knock-in mice
Method: single particle / : Torres JL, Jackson AM, Ozorowski G, Ward AB
EMDB-43191:
N332-GT5 SOSIP in complex with V1V3 polyclonal Fabs isolated at day 14 from N332-GT2 nanoparticle-immunized BG18HCgl knock-in mice
Method: single particle / : Ozorowski G, Torres JL, Ward AB
EMDB-43192:
N332-GT5 SOSIP in complex with V1V3 polyclonal Fabs isolated at day 15 from N332-GT5 nanoparticle-immunized BG18HCgl knock-in mice
Method: single particle / : Ozorowski G, Torres JL, Ward AB
EMDB-40822:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody IF1
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB
EMDB-40823:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody IF3
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40824:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody Base4
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
PDB-8swv:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody IF1
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB
PDB-8sww:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody IF3
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
PDB-8swx:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody Base4
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40825:
10E8-GT10.2 immunogen in complex with human Fab 10E8 and mouse Fab W6-10
Method: single particle / : Huang J, Ozorowski G, Ward AB
PDB-8sx3:
10E8-GT10.2 immunogen in complex with human Fab 10E8 and mouse Fab W6-10
Method: single particle / : Huang J, Ozorowski G, Ward AB
EMDB-40815:
BG505 SOSIP.664 in complex with wk26 human polyclonal antibodies C3V5, V1V3, N611 and base from participant 017
Method: single particle / : Karlinsey D, Ozorowski G, Ward AB
EMDB-40816:
BG505 SOSIP.664 in complex with wk26 human polyclonal antibodies gp41-N611/FP and base from participant 03
Method: single particle / : Karlinsey D, Ozorowski G, Ward AB
EMDB-40817:
BG505 SOSIP.664 in complex with wk26 human polyclonal antibodies gp41-N611/FP and base from participant 07
Method: single particle / : Karlinsey D, Ozorowski G, Ward AB
EMDB-40818:
BG505 SOSIP.664 in complex with wk26 human polyclonal antibodies gp120-GH and base from participant 09
Method: single particle / : Karlinsey D, Ozorowski G, Ward AB
EMDB-40819:
BG505 SOSIP.664 in complex with wk26 human polyclonal antibodies C3V5, V1V3, gp41-GH/FP and base from participant 11
Method: single particle / : Karlinsey D, Ozorowski G, Ward AB
Pages:
wwPDB to switch to version 3 of the EMDB data model
